Research Summary 9/23/2019

Limitations of surface disinfection

Contaminated environmental surfaces act as reservoirs of microorganisms (Hota B, 2004), which include several health-related pathogens (disease-causing microorganisms). As a result, contaminated surfaces can influence the incidence of infections in healthcare settings. It is one of the most common complications in health care facilities worldwide (Allegranzi B, 2010, Cookson B, 2013, Suetens C, 2013). Proper surface disinfection is recommended as the primary procedure for infection prevention (Rutala WA 1996, Sehulster L 2003, Mangram AJ 1999). However, the commonly used chemical disinfection methods have several disadvantages in controlling pathogens:

  • Limited effects of the biocidal product (Vandini A, 2014);
  • Rapid bacterial re-contamination of treated surfaces (occurs after 30 minutes) (Elisabetta Casell, 2017);
  • Development of drug-resistant microorganisms (although to date this has only been demonstrated in vitro) (Vandini A, 2014, Wand, 2017);
  • Environmental pollution (Vandini A, 2014);
  • Possible hypersensitivity of patients, staff and cleaners to chemical cleaners (Vandini A, 2014);
  • Resistance to widely used antiseptics and disinfectants (Frabetti A, 2009, Bock, 2016);
  • Both harmful (bad) and beneficial (good) microorganisms are killed (University of Ghent, 2007).

For these reasons, the importance of cleaning procedures to control the presence of pathogenic bacteria indicates the need for a new and sustainable strategy.

The use of probiotics is a new approach and a viable strategy

A promising strategy was first proposed by Falag and Macris in 2009. The basis of this strategy is the use of non-pathogenic microorganisms – probiotics (eg B. subtilis, B. pumilus and B. megaterium, etc.). Probiotic bacteria are spores of Bacillus spp, which are considered harmless microorganisms because, unlike disinfectants, they do not act as biocides. Probiotics are organic, easy to use and biodegradable. Detergents for probiotic microorganisms are based on the concept of “microbial control”, which no longer seeks to obtain a sterile environment, but instead creates a stable and healthy microbial community that provides a hygienically stable environment. Based on the principle of competitive exclusion (Gause’s Law) (Hibbing ME, 2010), probiotics are able to anchor and colonize cleaned surfaces to counteract the proliferation of other bacterial species (occupy area and consume all available food sources without allowing pathogenic bacteria to grow) (Gatesoupe FJ, 1999) , La Fauci 2015).

Research in health care institutions

Alberta Vandini in a study in 2014 compared the microbiological cleaning method with conventional cleaning methods. The study was conducted for 24 weeks in three independent hospitals (one in Belgium and two in Italy). About 20,000 test samples were collected from the surfaces to be cleaned.

The results of a study conducted in 2000 showed that microbial cleaning reduced the amount of pathogens associated with healthcare facilities by 50 to 89%. This effect was achieved after 3-4 weeks and the pathogen levels decreased steadily. While many questions remain about the true mechanisms, this study suggests that microbial cleaning is a more effective and sustainable alternative to dry cleaning and non-specific disinfection in healthcare settings.

Based on the results obtained, we can state that probiotics are effective and innovative products for environmental management. Probiotic-based cleaning strategies can greatly accelerate efforts to reduce the risk of infections in medical facilities, social care homes, and homes, thereby significantly improving health sustainability and providing a viable “green” alternative to the chemical disinfectants used to date.


  1. Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011; 377(9761):228–41. Epub 2010/12/15. doi: S0140-6736(10)61458-4 [pii] doi: 10. 1016/S0140-6736(10)61458-4 PMID: 21146207.
  2. Cookson B, Mackenzie D, Kafatos G, Jans B, Latour K, Moro ML, et al. Development and assessment of national performance indicators for infection prevention and control and antimicrobial stewardship in European long-term care facilities. J Hosp Infect. 2013; 85(1):45–53. Epub 2013/08/13. doi: S0195-6701(13)00194-1 [pii] doi: 10.1016/j.jhin.2013.04.019 PMID: 23932737.
  3. Suetens C, Hopkins S, Kolman J, Diaz Ho gberg L (2013).Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care hospitals. Stockholm, Sweden: European Centre for Disease Prevention and Control.
  4. Vandini A, Temmerman R, Frabetti A, Caselli E, Antonioli P, Balboni PG, et al. Hard surface biocontrol in hospitals using microbial-based cleaning products. PLoS One. 2014; 9(9):e108598. Epub 2014/09/27. doi: 10.1371/journal.pone.0108598 PONE-D-14-19956 [pii]. PMID: 25259528; PubMed Central PMCID: PMC4178175.
  5. Elisabetta Caselli, Maria D’Accolti, Alberta Vandini, Luca Lanzoni, Maria, Teresa Camerada, Maddalena Coccagna, Alessio Branchini3, Paola Antonioli, Pier Giorgio Balboni, Dario Di Luca, Sante Mazzacane. Impact of a Probiotic-Based Cleaning Intervention on the Microbiota Ecosystem of the Hospital Surfaces: Focus on the Resistome Remodulation.. DOI:10.1371/journal.pone.0148857. 2016.
  6. Hota B (2004) Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 39(8): 1182-1189.
  7. Rutala WA (1996) APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epidemiology, Inc. Am J Infect Control 24(4): 313-342.
  8. Sehulster L, Chinn RY, CDC, HICPAC (2003) Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 52(RR-10): 1-42.
  9. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 27(2): 97-132.
  10. Frabetti A, Vandini A, Balboni P, Triolo F, Mazzacane S (2009) Experimental evaluation of the efficacy of sanitation procedures in operating rooms. Am J Infect Control 37(8): 658-664.
  11. Vandini A, Frabetti A, Antonioli P, Platano D, Branchini A, et al. (2014) Reduction of the Microbiological Load on Hospital Surfaces. Through Probiotic-Based Cleaning Procedures: A New Strategy to Control Nosocomial Infections. J Microbiol Exp 1(5): 00027. DOI: 10.15406/jmen.2014.01.00027
  12. Elisabetta Casell (2017). Hygiene: microbial strategies to reduce pathogens and drug resistance in clinical settings. Microbial Biotechnology, 10, 1079–1083.
  13. Bock, L.J., Wand, M.E., and Sutton, J.M. (2016) Varying activity of chlorhexidine-based disinfectants against Klebsiella pneumoniae clinical isolates and adapted strains. J Hosp Infect 93: 42–48.
  14. Wand, M.E., Bock, L.J., Bonney, L.C. and Sutton, J.M. (2017) Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine. Antimicrob Agents Chemother 61: e01162–16.
  15. La Fauci V, Costa GB, Anastasi F, Facciolà A, Grillo OC, et al. (2015) An Innovative Approach to Hospital Sanitization Using Probiotics: In Vitro and Field Trials. J Microb Biochem Technol 7: 160-164. doi:10.4172/1948-5948.1000198
  16. Falagas ME, Makris GC (2009) Probiotic bacteria and biosurfactants for nosocomial infection control: a hypothesis. J Hosp Infect 71: 301–306.
  17. Hibbing ME, Fuqua C, Parsek MR, Peterson SB (2010) Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol 8: 15–25.
  18. Gatesoupe FJ (1999) The use of probiotics in aquaculture. Aquaculture 180: 147–165.